Interferon alpha-2b - Beijing Kawin Technology

Drug Profile

Interferon alpha-2b - Beijing Kawin Technology

Alternative Names: Interferon alpha-2b vaginal effervescent tablet - Beijing Kawin technology; Recombinant human interferon alpha-2b injection - Beijing Kawin technology

Latest Information Update: 28 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Beijing Kawin Technology Share-Holding
  • Class Antineoplastics; Antivirals; Interferons
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Basal cell cancer; Chronic myeloid leukaemia; Condylomata acuminata; Hairy cell leukaemia; Hepatitis B; Hepatitis C; Herpes zoster; Kaposi's sarcoma; Lymphoma; Malignant melanoma; Multiple myeloma; Ovarian cancer; Renal cancer; Uterine diseases

Most Recent Events

  • 17 Apr 2016 Biomarkers information updated
  • 27 Aug 2015 Launched for Basal cell cancer in China (Intratumoural) before August 2015
  • 27 Aug 2015 Launched for Chronic myeloid leukaemia in China (IM) before August 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top